Zobrazeno 1 - 10
of 136
pro vyhledávání: '"C, Meschievitz"'
Autor:
F Berut, Field F. Willingham, C Meschievitz, J C O'Donovan, K S Reisinger, Neal A. Halsey, L Pakula, M Blatter, G Bader, Mary Lou Thoms
Publikováno v:
The Pediatric Infectious Disease Journal. 16:675-679
Background. Advisory committees have recommended the increased use of inactivated poliovirus vaccine (IPV) for children. Objectives. The purpose of this study was to assess the safety and immunogenicity of three schedules using IPV administered with
Autor:
D. H. Van Thiel, Luis A. Balart, Gary L. Davis, Carlo H. Tamburro, Henry C. Bodenheimer, Terryl J. Ortego, Ira M. Jacobson, Alexandra L. Gibas, Robert P. Perrillo, J. Payne, Janice K. Albrecht, Jules L. Dienstag, C Meschievitz, Eugene R. Schiff, Jay H. Lefkowitch, Karen L. Lindsay, William D. Carey
Publikováno v:
Journal of Hepatology. 11:S31-S35
To assess the efficacy of therapy with the antiviral agent interferon in chronic hepatitis C (non-A, non-B hepatitis), we randomly assigned 166 chronic hepatitis C patients to treatment with either 3 million or 1 million units of recombinant interfer
Autor:
Woo, Yein1 (AUTHOR), Ma, Muyuan1 (AUTHOR), Okawa, Masashi1,2 (AUTHOR), Saito, Takeshi1,3,4,5 (AUTHOR) saitotak@usc.edu
Publikováno v:
Viruses (1999-4915). May2024, Vol. 16 Issue 5, p740. 13p.
Publikováno v:
Pediatrics. 91(4)
The objective of this study was to evaluate reactogenicity and immunogenicity of the recently US-licensed Connaught/BIKEN (C/B) acellular DTP (ADTP) vaccine as a booster for children aged 15 to 20 months after they had received either the C/B ADTP or
Autor:
R P, Perrillo, E R, Schiff, G L, Davis, H C, Bodenheimer, K, Lindsay, J, Payne, J L, Dienstag, C, O'Brien, C, Tamburro, I M, Jacobson, R, Sampliner, D, Feit, J, Lefkowitch, M, Kuhns, C, Meschievitz, B, Sanghvi, J, Albrecht, A, Gibas
Publikováno v:
The New England journal of medicine. 323(5)
Chronic hepatitis B is a common and often progressive liver disorder for which there is no accepted therapy. To assess the efficacy of treatment with interferon, we randomly assigned patients with chronic hepatitis B to one of the following regimens:
Autor:
Rong, Yangdan1 (AUTHOR), Ju, Xuegui2 (AUTHOR), Sun, Peng3 (AUTHOR), Wang, Yali1 (AUTHOR) wangyali610@163.com
Publikováno v:
BMC Infectious Diseases. 10/25/2023, Vol. 23 Issue 1, p1-15. 15p.
Autor:
C. Trepo, F. Zbulim, Xavier Causse, Hubert Godinot, Jean-Pierre Zarski, C. Meschievitz, T. Fontanges, Janice K. Albrecht, P. Chossegros
Publikováno v:
Journal of Hepatology. 11:S16
Autor:
Metin, Olga1 (AUTHOR), Zeybel, Müjdat2 (AUTHOR), Yurdaydin, Cihan2 (AUTHOR) cyurdaydin@ku.edu.tr
Publikováno v:
Liver International. 2023 Supplement1, Vol. 43 Issue 1, p60-68. 9p. 3 Charts.
Publikováno v:
In Controlled Clinical Trials 1988 9(3):270-270
Autor:
C. Meschievitz, R. Turner
Publikováno v:
Controlled Clinical Trials. 7:249